•  
  •  
  •  
  •  

2025-10-09 09:12:30

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Biocon Pharma Ltd in partnership with Carnegie Pharmaceuticals LLC receives USFDA tentative approval for Rifaximin Tablets
  • Revolt Motors fuels India's Racing Future with Sponsorship of Young Racer Ethan Joy at F4 India Championship
  • Simplex Realty Limited enters into supplemental agreement for redevelopment project
  • Ameenji Rubber Ltd. debuts on BSE SME Exchange
  • Mahanagar Gas Ltd signs MoU with Oil India Ltd to collaborate across the LNG value chain

Keywords Selected:  BergerPaintsIndia

Stock Report

  • Berger Paints India Limited recommends dividend of Rs. 3.80
  • Berger Paints India Ltd consolidated Q4 FY2025 PAT at Rs. 262.05 crores
  • Berger Paints India Ltd Q2 FY2025 consolidated PAT falls to Rs. 269.66 crores
  • Berger Paints India Ltd recommends dividend of Rs. 3.50
  • Berger Paints India Ltd posts consolidated PAT of Rs. 222.10 crores in Q4 FY2024
  • Berger Paints India Ltd gets land allotment for new facility in Odisha
  • Berger Paints India Ltd posts Rs. 291.64 crores consolidated PAT in Q2 FY24
  • Berger Paints India Ltd Q1 FY2024 consolidated net profit soars to Rs. 354.35 crores
  • Berger Paints India Ltd recommends dividend of Rs. 3.20
  • Berger Paints India Ltd posts Rs. 185.69 crores consolidated PAT in Q4 FY23
  • Berger Paints India Ltd Q3 FY23 consolidated net profit lower at Rs. 200.94 crores
  • Berger Paints India Ltd reports Rs. 219.36 crores consolidated profit in Q2 FY2022-23
  • Berger Paints India Ltd consolidated Q1 FY2023 PAT rises to Rs. 253.43 crores
  • Berger Paints India Ltd posts consolidated net profit of Rs. 220.66 crores in Q4FY22
  • Berger Paints India posts Rs. 252.72 crores consolidated PAT in Q3 FY22
  • Berger Paints India Ltd consolidated Q2FY22 PAT at Rs. 218.85 crore

Latest Post

  • Biocon Pharma Ltd in partnership with Carnegie Pharmaceuticals LLC receives USFDA tentative approval for Rifaximin Tablets
  • Revolt Motors fuels India's Racing Future with Sponsorship of Young Racer Ethan Joy at F4 India Championship
  • Simplex Realty Limited enters into supplemental agreement for redevelopment project
  • Ameenji Rubber Ltd. debuts on BSE SME Exchange
  • Mahanagar Gas Ltd signs MoU with Oil India Ltd to collaborate across the LNG value chain


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024